Comighod, April Shyne B.

HRN: 23-06-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2023
CEFUROXIME 500MG (TAB)
05/22/2023
05/29/2023
PO
500mg
BID X 7days
Urinary Tract Infection
Waiting Final Action 
08/01/2023
CEFUROXIME 1.5GM (VIAL)
08/02/2023
08/03/2023
IV
1.5g
Q8
Stat CS
Waiting Final Action 
08/02/2023
CEFUROXIME 1.5GM (VIAL)
08/02/2023
08/04/2023
IV
1.5gm
Q8H X 6 Doses
S/p CS
Waiting Final Action 
08/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2023
08/04/2023
IV
500mg
Q8H
S/p CS
Waiting Final Action 
08/03/2023
CEFUROXIME 500MG (TAB)
08/03/2023
08/09/2023
PO
500
BID
S/P LTCS
Waiting Final Action 
08/03/2023
METRONIDAZOLE 500MG (TAB)
08/03/2023
08/09/2023
PO
500mg
TID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: